• Confirmed Opentec orders > $5.7 M in Q2 expected to settle on 28th of February 2025
• US Hazavoid Capital Raise Offer, Hazavoid Tx LCC capital valuation model and Memorandum of Understanding are now actively in the market aimed to raise minimum $2.5M USD
• Inventis 2024 Annual General Meeting approved the share sale of 49% ECD equity, however a better offer has been received since 30 December-24 from Ant software Pty Ltd

Inventis Limited (ASX:IVT) has provided an amended Operational Review and Appendix 4C for the quarter ended 31 December 2024. The key highlights include: Confirmed Opentec orders > $5.7 M in Q2 expected to settle on 28th of February 2025; US Hazavoid Capital Raise Offer, Hazavoid Tx LCC capital valuation model and Memorandum of Understanding are now actively in the market aimed to raise minimum $2.5M USD; Inventis 2024 Annual General Meeting approved the share sale of 49% ECD equity, however a better offer has been received since 30 December-24 from Ant software Pty Ltd, which will be confirmed and details sought; Developed recurring revenue funding facility for Hazavoid LCC 'Lease to Buy' and scoping work has commenced for the new Hazavoid App and associated recurring revenue subscription model; The PO for the next stage of the new Hazavoid Storm Alert for Western Sydney Airport is confirmed and delivery is expected by the end of FY25; Technology has lodged 2 x New Government Export Funding Grants; Q2 Delivery in full and on time KPI's (DIFOT) remains high, within the range of 92.9%-100% across various divisions; and Total Network sales (inc. 49% Winya associate) up 4% YOY. The Technology Division has increased its overall pipeline with various international quotes being completed in the Q2 period. The Philippine Hazavoid order for Palawan stage 1 has now been received, with additional stages expected in Q3 and Q4. The Hazavoid business in the USA has commenced sales and has developed a qualified pipeline of client quotes of over AUD$3.4M. The Company is in detailed discussions to raise $2.5 million in USD through an equity placement in Hazavoid Tx LLC USA, and through opportunities with Convertible Notes.

The Company is in detailed discussions to raise $2.5 million in USD through an equity placement in Hazavoid Tx LLC USA, and through opportunities with Convertible Notes. The ECD plan potentially unlocks $1.2- $1.5 million of cash (before costs) to the Group.

The Company is seeking various opportunities to release cash in the coming months, including discussions with AFG Venture Group and industry Growth funds to help fuel the capital needs of the group, given the robust Hazavoid valuation received and early indications of the size and magnitude of the Global Market. Early preliminary interest in a $8-$10M investment into the transformation plan to help fuel international growth with the global expansion, including ECD, is being explored.